Skip to main content
Donate

Researchers

About Our Scientific Advisory Board

These individuals review and give constructive feedback in a standardized manner on the translational relevance, scientific rigor, track record and expertise of the investigator, overall impact of the project as it relates to the mission of FAST, the proposed timeline, the associated budget of the project, and overall feasibility of the suggested research. This process is led by the chair of the Scientific Advisory Board, Dr. Barbara Bailus. At the same time, legal teams negotiate a contract to govern the grant and any advancements that may come from the grant. If and when the grant is scored in a range of high impact and approved by the chair of the SAB, the Chief Science Officer, and the entire FAST Board of Directors, then the contract is signed and the work can begin immediately.

For a list of all FAST-funded research projects, visit us here.

FAST Angelman Syndrome News

Disclaimer

This website contains information for a broad audience and may include information on current and upcoming programs that are not yet approved or accessible The information provided is for general informational purposes only and is not intended as medical advice, diagnosis, or treatment. While FAST strives to provide accurate and up-to-date information, the content on this site may not always reflect the most current research or clinical guidelines. The inclusion of clinical trial information, treatments or specific healthcare providers does not imply endorsement, recommendation or guarantee of safety, efficacy, or availability. Reliance on any information provided by this website is solely at your own risk. FAST disclaims any liability for any errors or omissions in the information provided or for any decisions made based on this information. For personalized medical advice or specific health concerns including participation in any clinical trial, please consult a qualified healthcare professional.